We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Fenretinide and Lonafarnib in Treating Patients With Advanced or Recurrent Head and Neck Cancer

This study has been terminated.
(Slow Accrual.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00103090
First Posted: February 8, 2005
Last Update Posted: November 14, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2006
  Primary Completion Date: January 2006 (Final data collection date for primary outcome measure)